StockData
Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc. (PBYI) stock

PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.22+0.08 (+1.12%)

Close on Nov 18, 2026Market cap $372.70MP/E 13.9Yield –

Puma Biotechnology gross margin

Gross margin is gross profit as a percentage of revenue.

Puma Biotechnology's gross margin for the twelve months ending Jun 30, 2026 was 74.8%. For fiscal 2025 it was 74.5%, against 72.1% the year before. The highest annual figure on record is 86.5% in fiscal 2019.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202574.5%+2.5
FY2024Dec 31, 202472.1%−1.3
FY2023Dec 31, 202373.4%−2.4
FY2022Dec 31, 202275.8%+1.0
FY2021Dec 31, 202174.8%−7.7
FY2020Dec 31, 202082.5%−4.0
FY2019Dec 31, 201986.5%+0.3
FY2018Dec 31, 201886.2%+6.3
FY2017Dec 31, 201779.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202677.9%+1.4
Q1 FY2026Mar 31, 202676.7%−0.3
Q4 FY2025Dec 31, 202569.3%−7.1
Q3 FY2025Sep 30, 202577.7%+13.8
Q2 FY2025Jun 30, 202576.5%−0.8
Q1 FY2025Mar 31, 202577.1%+1.6
Q4 FY2024Dec 31, 202476.4%+10.1
Q3 FY2024Sep 30, 202463.9%−12.5
Q2 FY2024Jun 30, 202477.4%−0.9
Q1 FY2024Mar 31, 202475.5%+0.5
Q4 FY2023Dec 31, 202366.3%−8.1
Q3 FY2023Sep 30, 202376.3%−1.8
Q2 FY2023Jun 30, 202378.3%+3.3
Q1 FY2023Mar 31, 202375.0%−1.3
Q4 FY2022Dec 31, 202274.4%−4.1
Q3 FY2022Sep 30, 202278.1%+0.3
Q2 FY2022Jun 30, 202274.9%−2.6
Q1 FY2022Mar 31, 202276.3%+6.4
Q4 FY2021Dec 31, 202178.5%−0.7
Q3 FY2021Sep 30, 202177.8%−2.6
Q2 FY2021Jun 30, 202177.6%−5.1
Q1 FY2021Mar 31, 202169.9%−22.0
Q4 FY2020Dec 31, 202079.2%−6.2
Q3 FY2020Sep 30, 202080.4%−5.1
Q2 FY2019Jun 30, 201982.7%+0.1
Q1 FY2019Mar 31, 201991.9%+1.5
Q4 FY2018Dec 31, 201885.4%+4.2
Q3 FY2018Sep 30, 201885.6%+10.7
Q2 FY2018Jun 30, 201882.6%–
Q1 FY2018Mar 31, 201890.4%–
Q4 FY2017Dec 31, 201781.3%–
Q3 FY2017Sep 30, 201774.9%–

More Puma Biotechnology figures

See a number that looks wrong?